Development of a high affinity Anticalin ® directed against human CD98hc for theranostic applications

Conclusion: Our findings provide a first proof of concept to exploit CD98hc for non-invasive biomedical imaging. The novel Anticalin-based αhCD98hc radiopharmaceutical constitutes a promising tool for preclinical and, potentially, clinical applications in oncology.

Source: Theranostics - July 3, 2020 Category: Molecular Biology Authors: Friedrich-Christian Deuschle, Volker Morath, Andr é Schiefner, Corinna Brandt, Simone Ballke, Sybille Reder, Katja Steiger, Markus Schwaiger, Wolfgang Weber, Arne Skerra Tags: Research Paper Source Type: research